Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity-From Bench to Bedside.

导出 LinkOut

翻译打印收藏纠错

作者： Mattan,Levi ^[1] ; Tal,Goshen-Lago ^[2] ; Rinat,Yerushalmi ^[3] ; Tal,Granot ^[4] ; Salomon M,Stemmer ^[3] ; Ruth,Shalgi ^[3] ; Irit,Ben-Aharon ^[4]

作者单位： Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel. ^[1] Division of Oncology, Rambam Health Care Campus, Haifa 3109601, Israel. ^[2] Institute of Oncology, Davidoff Center, Beilinson Campus, Rabin Medical Center, Petah-Tiqva 49100, Israel. ^[3] Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel. ^[4] Rappaport Faculty of Medicine, Technion, Haifa 3200003, Israel. ^[5]

关键词 anti-HER2/neu chemotherapy ovarian toxicity trastuzumab

DOI 10.3390/biomedicines8120577

PMID 33297351

发布时间 2020-12-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomedicines

2020年8卷12期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity-From Bench to Bedside.

Biomedicines

相似文献

Biomedicines

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity-From Bench to Bedside.

Biomedicines

相似文献

Biomedicines

相关期刊

检索历史清除